An Explorative, Open, Single-arm Clinical Investigation to Collect Real-life Measurement Data in Order to Assess the Mathematical Algorithms Involved in TENA SmartCare Change Indicator.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Urinary Incontinence
- Sponsor
- Essity Hygiene and Health AB
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Urine Volume Quantification and Impedance Measurements
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This study is an explorative, open, single-arm clinical investigation to collect real-life measurement data in order to assess the mathematical algorithms involved in TENA SmartCare Change Indicator.
Detailed Description
The purpose of this exploratory clinical investigation is to evaluate safety and to collect real-life measurement data using the TENA SmartCare Change Indicator. The collected data will be used to assess the device related algorithms. These algorithms have been established and verified in a laboratory environment. However, due to possible differences in parameters, real-life measurement data are to be collected to aid in further product development.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The subject is willing and able to provide informed consent and to participate in the clinical investigation.
- •The subject is ≥18 years of age.
- •The subject is diagnosed with urinary incontinence.
- •The subject is being cared for at Tre Stiftelser.
Exclusion Criteria
- •The subject has ≥ 4 fecal "incidences" per week.
- •The subject has severe absorbent product related skin problems, as judged by the investigator.
- •The subject is hyper sensitive related to allergic reaction to any of the included materials, as judged by the investigator.
- •The subject has ≥ 2 intermittent urinary catheters per day.
- •The subject has a pacemaker or an implantable cardioverter-defibrillator.
- •The subject removes the incontinence product.
- •The subject demonstrates responsive behavior towards sensors.
- •The subject has any other condition that may make participation in the clinical investigation inappropriate, as judged by investigator.
- •The subject is not cared for at Tre Stiftelser.
- •The subject is pregnant or lactating.
Outcomes
Primary Outcomes
Urine Volume Quantification and Impedance Measurements
Time Frame: 11 weeks
Descriptive statistics were used to summarize any individual differences between the predicted urine volume from the Change Indicator and the true urine volume (by measuring absorbent product weight). A measure of mean difference for the predicted volume minus true volume is assessed. A combination of these values were used to assess the mathematical algorithms for the TENA SmartCare Change Indicator.